Journal Title
Molecular Cancer

MOL CANCER

ISSN / eISSN
1476-4598 / 1476-4598
Aims and Scope
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

ONCOLOGY

CiteScore
64.90 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Cancer Research Q1 #2/214
Biochemistry, Genetics and Molecular Biology - Molecular Medicine Q1 #2/171
Biochemistry, Genetics and Molecular Biology - Oncology Q1 #4/366
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q1
ONCOLOGY - SCIE Q1
H-index
103
Country/Area of Publication
ENGLAND
Publisher
BioMed Central
Publication Frequency
Monthly
Year Publication Started
2002
Annual Article Volume
167
Open Access
YES
Contact
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
This journal was included in the warning list by our school before the new year and is not recognized. Four articles were submitted by colleagues in our department, and all of them were accepted. The proportion of Chinese authors is very high, and it is indeed of relatively low quality. It was a waste of time.
2023-04-20
Nous avons tellement de chance d'avoir soumis deux articles à l'été 2020, et ils ont été acceptés après des révisions modérées à majeures. Ils ont été publiés dans le journal à la fin de 2020.
2021-01-17

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started